Suppr超能文献

运动障碍学会非运动症状评定量表:初步验证研究。

The movement disorder society nonmotor rating scale: Initial validation study.

机构信息

King's College London, Department of Neurosciences, Institute of Psychiatry, Psychology & Neuroscience and Parkinson Foundation Centre of Excellence, King's College Hospital, Denmark Hill, London, UK.

Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, UK.

出版信息

Mov Disord. 2020 Jan;35(1):116-133. doi: 10.1002/mds.27862. Epub 2019 Sep 30.

Abstract

BACKGROUND

The Movement Disorder Society-sponsored Nonmotor Rating Scale is an update of the existing Parkinson's disease Nonmotor Symptoms Scale modified to address some limitations in Nonmotor Symptoms Scale scoring, structure, and symptom coverage.

METHODS

PD patients were recruited from movement disorder centers in an international, multicenter study. The Movement Disorder Society Nonmotor Rating Scale, consisting of 13 domains plus a subscale for nonmotor fluctuations, was rater administered, along with the Nonmotor Symptoms Scale and other clinical assessments. Standard reliability and validity testing were conducted.

RESULTS

Four hundred and two PD patients were recruited (mean age ± standard deviation, 67.42 ± 9.96 years; mean age at PD onset ± standard deviation, 59.27 ± 10.67 years; median Hoehn and Yahr stage 2 (interquartile range 2-3). Data quality was satisfactory for all Movement Disorder Society Nonmotor Rating Scale domains except sexual (6.7% missing data). There were no floor or ceiling effects for the Movement Disorder Society Nonmotor Rating Scale and nonmotor fluctuations total score; domains had no ceiling effects, but some floor effects (13.5%-83.5%). The Movement Disorder Society Nonmotor Rating Scale and nonmotor fluctuations total score internal consistency were acceptable (average Cronbach's alpha, 0.66 and 0.84, respectively); interrater reliability was excellent (intraclass correlation coefficient, >0.95); for test-retest reliability, the intraclass correlation coefficient was 0.84 for the Movement Disorder Society Nonmotor Rating Scale and 0.70 for Movement Disorder Society nonmotor fluctuations total score, and precision was excellent for the Movement Disorder Society Nonmotor Rating Scale (standard error of measurement, 25.30) and fair for nonmotor fluctuations (standard error of measurement, 7.06). Correlations between Movement Disorder Society Nonmotor Rating Scale score and the corresponding Nonmotor Symptoms Scale and Movement Disorder Society UPDRS scores were high. There were no significant sex or age effects. The Movement Disorder Society Nonmotor Rating Scale score increased with increasing PD duration, disease severity, and PD medication dose (all P < 0.001).

CONCLUSIONS

The Movement Disorder Society Nonmotor Rating Scale is a valid measure for measuring the burden of a wide range of Nonmotor Rating Scale scores, including nonmotor fluctuations, in PD patients. © 2019 International Parkinson and Movement Disorder Society.

摘要

背景

运动障碍协会赞助的非运动评分量表是对现有帕金森病非运动症状量表的更新,旨在解决非运动症状量表评分、结构和症状涵盖范围的一些限制。

方法

这项国际性、多中心研究从运动障碍中心招募了 PD 患者。运动障碍协会非运动评分量表由 13 个领域组成,加上非运动波动的子量表,由评估者进行评估,同时还进行了非运动症状量表和其他临床评估。进行了标准的可靠性和有效性测试。

结果

共招募了 402 名 PD 患者(平均年龄±标准差,67.42±9.96 岁;平均 PD 发病年龄±标准差,59.27±10.67 岁;中位数 Hoehn 和 Yahr 分期 2 级(四分位间距 2-3)。除了性(6.7%数据缺失)之外,所有运动障碍协会非运动评分量表领域的数据质量均令人满意。运动障碍协会非运动评分量表和非运动波动总分均无地板效应或天花板效应;各领域均无天花板效应,但存在一些地板效应(13.5%-83.5%)。运动障碍协会非运动评分量表和非运动波动总分的内部一致性可接受(平均 Cronbach's alpha 分别为 0.66 和 0.84);评估者间的可靠性极好(组内相关系数>0.95);对于测试-重测可靠性,运动障碍协会非运动评分量表的组内相关系数为 0.84,运动障碍协会非运动波动总分的组内相关系数为 0.70,运动障碍协会非运动评分量表的精密度极好(测量误差标准,25.30),非运动波动的精密度为中等(测量误差标准,7.06)。运动障碍协会非运动评分量表得分与相应的非运动症状量表和运动障碍协会 UPDRS 评分之间存在高度相关性。无明显的性别或年龄效应。运动障碍协会非运动评分量表得分随 PD 持续时间、疾病严重程度和 PD 药物剂量的增加而增加(均 P<0.001)。

结论

运动障碍协会非运动评分量表是一种有效的测量工具,可用于测量 PD 患者广泛的非运动评分量表评分,包括非运动波动。© 2019 国际帕金森病和运动障碍协会。

相似文献

1
The movement disorder society nonmotor rating scale: Initial validation study.
Mov Disord. 2020 Jan;35(1):116-133. doi: 10.1002/mds.27862. Epub 2019 Sep 30.
2
Validation of the MDS-UPDRS Part I for nonmotor symptoms in Parkinson's disease.
Mov Disord. 2012 Jan;27(1):79-83. doi: 10.1002/mds.23939. Epub 2011 Sep 13.
3
The Parkinson's Disease Composite Scale: results of the first validation study.
Eur J Neurol. 2018 Mar;25(3):503-511. doi: 10.1111/ene.13529. Epub 2018 Jan 13.
4
Non-Motor Fluctuations in Parkinson's Disease: Validation of the Non-Motor Fluctuation Assessment Questionnaire.
Mov Disord. 2021 Jun;36(6):1392-1400. doi: 10.1002/mds.28507. Epub 2021 Feb 15.
5
Extensive validation study of the Parkinson's Disease Composite Scale.
Eur J Neurol. 2019 Oct;26(10):1281-1288. doi: 10.1111/ene.13976. Epub 2019 May 31.
6
Validation of the Italian version of the Non Motor Symptoms Scale for Parkinson's disease.
Parkinsonism Relat Disord. 2017 Jan;34:38-42. doi: 10.1016/j.parkreldis.2016.10.020. Epub 2016 Oct 24.
7
International study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease.
Neurology. 2009 Nov 10;73(19):1584-91. doi: 10.1212/WNL.0b013e3181c0d416.
8
Factor Analysis and Clustering of the Movement Disorder Society-Non-Motor Rating Scale.
Mov Disord. 2020 Jun;35(6):969-975. doi: 10.1002/mds.28002. Epub 2020 Mar 27.
9
Validation of the Parkinson Fatigue Scale in Chinese Parkinson's disease patients.
Brain Behav. 2017 May 2;7(6):e00712. doi: 10.1002/brb3.712. eCollection 2017 Jun.
10
Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease.
J Am Geriatr Soc. 2004 May;52(5):784-8. doi: 10.1111/j.1532-5415.2004.52219.x.

引用本文的文献

1
Factors Influencing Pain Management Practices in People With Parkinson's Disease: A Qualitative Descriptive Study.
Parkinsons Dis. 2025 Aug 1;2025:1231126. doi: 10.1155/padi/1231126. eCollection 2025.
4
Research progress of assessment tools for Parkinson's disease psychosis in China.
Front Psychiatry. 2025 Jul 10;16:1588618. doi: 10.3389/fpsyt.2025.1588618. eCollection 2025.
5
CSF Biomarker-Based Cognitive Trajectories in Parkinson's Disease-Subjective Cognitive Decline.
Ann Clin Transl Neurol. 2025 Aug;12(8):1575-1584. doi: 10.1002/acn3.70075. Epub 2025 Jun 11.
6
Correlation between non-motor symptoms and eye movements in Parkinson's disease patients.
Neurol Sci. 2025 Jun;46(6):2665-2673. doi: 10.1007/s10072-025-08081-2. Epub 2025 Mar 7.
8
Pain and fatigue in Parkinson's disease: advances in diagnosis and management.
Neurol Sci. 2025 Jun;46(6):2437-2454. doi: 10.1007/s10072-024-07985-9. Epub 2025 Feb 12.
10
Non-Motor Fluctuations in Parkinson's Disease: Underdiagnosed Yet Important.
J Mov Disord. 2025 Jan;18(1):1-16. doi: 10.14802/jmd.24227. Epub 2024 Dec 20.

本文引用的文献

1
Should there be less emphasis on levodopa-induced dyskinesia in Parkinson's disease?
Mov Disord. 2019 Jun;34(6):816-819. doi: 10.1002/mds.27691. Epub 2019 Apr 14.
2
Pilot Study of the International Parkinson and Movement Disorder Society-sponsored Non-motor Rating Scale (MDS-NMS).
Mov Disord Clin Pract. 2019 Feb 5;6(3):227-234. doi: 10.1002/mdc3.12728. eCollection 2019 Mar.
3
EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease.
Mov Disord. 2019 Mar;34(3):353-365. doi: 10.1002/mds.27626. Epub 2019 Feb 4.
4
Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review.
Mov Disord. 2019 Feb;34(2):180-198. doi: 10.1002/mds.27602. Epub 2019 Jan 17.
5
Levodopa-carbidopa intestinal gel in a subgroup of patients with dyskinesia at baseline from the GLORIA Registry.
Neurodegener Dis Manag. 2019 Feb;9(1):39-46. doi: 10.2217/nmt-2018-0034. Epub 2018 Dec 14.
6
The Neuropsychiatric Fluctuations Scale for Parkinson's Disease: A Pilot Study.
Mov Disord Clin Pract. 2018 Mar 23;5(3):265-272. doi: 10.1002/mdc3.12607. eCollection 2018 May-Jun.
8
Evaluation of nocturnal hypokinesia in Parkinson's disease using a novel patient/proxy questionnaire and correlations with objective monitoring.
Parkinsonism Relat Disord. 2019 Apr;61:219-223. doi: 10.1016/j.parkreldis.2018.09.023. Epub 2018 Sep 21.
10
Non-motor Parkinson disease: new concepts and personalised management.
Med J Aust. 2018 May 21;208(9):404-409. doi: 10.5694/mja17.00993.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验